Gene Solutions Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $5.33M

  • Investors
  • 2

Gene Solutions General Information

Description

Developer of mitochondrial therapeutics designed to enhance drug pipelines in the field of central nervous system diseases. The company's therapeutics utilize its proprietary mitochondrial genomic targets, develop accurate and effective clinical diagnostic methods for these diseases, and facilitate the development of therapeutic compounds, enabling healthcare providers to treat diseases such as Alzheimer's, Parkinson's, and Schizophrenia.

Contact Information

Website
www.mitodna.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 123 East Main Street
  • Suite 5
  • Charlottesville, VA 22902
  • United States
+1 (434)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Pharmaceuticals
Drug Discovery
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 123 East Main Street
  • Suite 5
  • Charlottesville, VA 22902
  • United States
+1 (434)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gene Solutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 31-May-2024 $5.33M Completed Generating Revenue
4. Later Stage VC 02-Oct-2015 Completed Generating Revenue
3. Seed Round 25-Feb-2013 Completed Generating Revenue
2. Grant 01-Jan-2010 $22.5K $350K Completed Generating Revenue
1. Angel (individual) 26-Aug-2008 $350K $350K Completed Startup
To view Gene Solutions’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Gene Solutions Patents

Gene Solutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20060194239-A1 Using presence of mutation in nadh dehydrogenase gene as evaluative tool in diagnosis of neurodegenerative disorders Active 25-Feb-2005
US-20110045460-A1 Mitochondrial complex i mutations in parkinson's disease & aging Inactive 25-Feb-2005
US-7537893-B2 Using presence of mutation in nadh dehydrogenase gene as evaluative tool in diagnosis of neurodegenerative disorders Active 25-Feb-2005 C12Q1/6883

Gene Solutions Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gene Solutions Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
PIPV Capital PE/Buyout Minority
University of Virginia University
To view Gene Solutions’s complete investors history, request access »

Gene Solutions FAQs

  • When was Gene Solutions founded?

    Gene Solutions was founded in 2006.

  • Where is Gene Solutions headquartered?

    Gene Solutions is headquartered in Charlottesville, VA.

  • What is the size of Gene Solutions?

    Gene Solutions has 2 total employees.

  • What industry is Gene Solutions in?

    Gene Solutions’s primary industry is Biotechnology.

  • Is Gene Solutions a private or public company?

    Gene Solutions is a Private company.

  • What is Gene Solutions’s current revenue?

    The current revenue for Gene Solutions is .

  • How much funding has Gene Solutions raised over time?

    Gene Solutions has raised $6.62M.

  • Who are Gene Solutions’s investors?

    PIPV Capital and University of Virginia have invested in Gene Solutions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »